Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Pulmonary arterial hypertension
Drug- or toxin-induced pulmonary arterial hypertension
Drug- or toxin-induced pulmonary arterial hypertension (PAH) is a form of pulmonary arterial hypertension (PAH) secondary to the exposition to drugs. Drug- or toxin-induced PAH is characterized by elevated pulmonary arterial resistance leading to right heart failure. Drug or toxin induced PAH is progressive and potentially fatal.
This condition has no sub-types.